Fludrocortisone Acetate(Fludrocortisone) - Uses, Dosage and Side Effects

Fludrocortisone Acetate for dogs and cats is a synthetic mineralocorticoid used to manage hypoadrenocorticism, commonly known as Addison's disease.

Addison's disease is diagnosed most frequently in young to middle-aged female dogs. Breeds with a higher predisposition include Standard Poodles, Bearded Collies, Portuguese Water Dogs, and Nova Scotia Duck Tolling Retrievers.

Fludrocortisone acts on mineralocorticoid receptors in the kidney tubules, mimicking aldosterone. It signals the kidneys to retain sodium and excrete potassium in the urine. Think of it as restoring the kidney's ability to hold onto the right minerals and flush out the ones that build up to dangerous levels without adrenal function. By restoring sodium and potassium balance, fludrocortisone stabilises cardiovascular function, blood pressure, and overall fluid balance in dogs with Addison's disease.

It works identically in cats. Fludrocortisone binds to mineralocorticoid receptors in the renal tubules, correcting the sodium loss and potassium retention characteristic of aldosterone deficiency. Cats with Addison's disease are rarer than dogs but present with similar electrolyte disturbances, weakness, and gastrointestinal signs, such as loss of appetite, weight loss, and vomiting. Lifelong mineralocorticoid replacement is required in affected cats, as the adrenal glands do not recover their function.

Fludrocortisone Acetate dosage for dogs is weight-based and given orally once daily. Electrolyte monitoring (sodium and potassium blood levels) is the primary tool for dose adjustment. Most dogs require dose increases over the first 6 to 18 months of treatment as the body's requirements become clearer. Some dogs require dietary sodium supplementation alongside fludrocortisone during the initial management period. Do not adjust the dose without veterinary guidance and supporting electrolyte results.

The dosing approach is the same across all size groups. Small dogs receive lower total doses based on body weight. Accurate weight measurement and electrolyte monitoring every 1 to 3 months are especially important in small breeds, where even minor electrolyte fluctuations can quickly cause clinical signs.

Weight-based once-daily dosing and regular electrolyte rechecks apply consistently. Medium-sized dogs on a stable long-term dose may require electrolyte monitoring every 3 to 6 months once a consistent maintenance dose is established.

Large dogs require higher total doses based on body weight. Large breeds predisposed to Addison's disease, such as Standard Poodles, may require dose increases over time as the disease progresses. Body weight changes significantly affect dose requirements and should prompt an electrolyte recheck in large breeds.

Fludrocortisone Acetate dosage for cats is also weight-based and given orally once daily. Cats with Addison's disease often require concurrent low-dose prednisolone for glucocorticoid replacement alongside fludrocortisone. Electrolyte monitoring every 1 to 3 months during dose stabilisation and every 6 months during maintenance is standard practice in feline Addison's disease management.

Addison's disease in kittens is extremely rare. If diagnosed, immediate emergency stabilisation and specialist endocrinological assessment at a 24/7 feline care facility are required before oral fludrocortisone therapy is initiated. Dosing requires precise, weight-based calculation and frequent monitoring, given the challenges of managing electrolytes in rapidly growing young patients.

Side effects from fludrocortisone are most commonly related to mineralocorticoid excess from overdosing.

Possible side effects in dogs include:

Cats may experience increased thirst and urination, hypertension, and fluid retention at excessive doses. Cats are generally more sensitive to steroid-related effects. Electrolyte monitoring and blood pressure assessment at regular intervals are essential throughout long-term fludrocortisone treatment in cats.

Fludrocortisone overdose in dogs causes excessive sodium and water retention, leading to hypertension, oedema, and hypokalaemia. Severe overdose may cause cardiovascular complications, including arrhythmias from low potassium. Contact your pet health expert immediately if overdose is suspected or if a dog on fludrocortisone develops sudden hypertension, significant fluid retention, or severe weakness. Dose reduction and supportive management are required under veterinary supervision.

Cats are more sensitive to mineralocorticoid excess. Overdose signs include significant fluid retention, hypertension, hypokalaemia-related weakness, and cardiovascular changes. Seek immediate veterinary care if overdose is suspected in a cat on fludrocortisone, particularly in those with pre-existing cardiac or renal disease where fluid and electrolyte disturbances are less well tolerated.

Store fludrocortisone acetate tablets at room temperature away from direct sunlight, heat, and moisture. Keep in the original packaging with the lid tightly sealed. Store out of reach of children and pets. Do not use after the expiry date printed on the packaging. Do not transfer to an unlabelled container.

Contact your vet immediately if your pet develops sudden profound weakness, collapse, severe vomiting, reduced urine output, swollen limbs, or significant changes in thirst and urination during fludrocortisone treatment. These signs may indicate electrolyte crisis from under- or over-replacement, cardiovascular complications, or an intercurrent illness that disrupts adrenal hormone requirements. Pets with Addison's disease also require dose increases during periods of stress, illness, or surgery, a protocol your vet will advise on specifically.

Fludrocortisone Acetate for dogs and cats is the cornerstone of long-term mineralocorticoid replacement in Addison's disease management. Consistent daily administration, regular electrolyte monitoring, and careful dose titration based on blood results rather than clinical impression alone are essential for stable long-term control. Most dogs and cats with Addison's disease live a normal quality of life with appropriate management, provided monitoring is maintained, and dose adjustments are made proactively throughout the patient's life.Fludrocortisone Acetate for dogs and cats is the cornerstone of long-term mineralocorticoid replacement in Addison's disease management. Consistent daily administration, regular electrolyte monitoring, and careful dose titration based on blood results rather than clinical impression alone are essential for stable long-term control. Most dogs and cats with Addison's disease live a normal quality of life with appropriate management, provided monitoring is maintained, and dose adjustments are made proactively throughout the patient's life.